Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine
Ralf Buettner(City Of Hope National Medical Center), Steven T. Rosen(City of Hope)
Cited by 66
Related Papers
Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines
|Molecular Cancer Therapeutics|2006|81
SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma
|Journal of Experimental & Clinical Cancer Research|2022|55
Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine
|Journal of Biological Chemistry|2009|44
SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide
|Cancer Gene Therapy|2022|20